PetVivo Holdings, Inc. will hold a conference call on November 14, 2025, to discuss results for the fiscal second quarter ended September 30, 2025. The call will be hosted by PetVivo management and a replay of the webcast will be available. PetVivo is an emerging biomedical device company focused on innovative medical devices and therapeutics for companion animals. They have a robust pipeline of products for animals and people, including SPRYNG® with OsteoCushion® technology for joint afflictions and PrecisePRP® for veterinarians. The company’s forward-looking statements are available in their Annual Report on Form 10-K for the year ended March 31, 2025.

Read more at GlobeNewswire: PetVivo Sets Fiscal Second Quarter 2026 Conference Call for